top of page
Microbiota I-Center (MagIC) is a leading microbiome research center dedicated to advancing microbiome science for personalized healthcare. Our goal is to unravel the connections between the human gut microbiome and health to develop microbiome therapeutics.
Our research focuses on the impact of gut microbiome on various health conditions, including chronic diseases, mental health, and metabolic disorders. By leveraging cutting-edge technologies and big data analytics, we aim to enhance our understanding of the microbiome's role in health and disease.
MagIC serves as a hub for interdisciplinary collaboration, bringing together microbiome researchers, industry partners, and healthcare professionals. Together, we translate scientific discoveries into practical applications, driving the development of microbiome-based products and services that can benefit patients and the broader community in Hong Kong and beyond.
At MagIC, our mission is to develop effective and accessible microbiome diagnostics
and therapeutics to improve human health.
Diagnostic Development
Therapeutics Development
MagIC is dedicated to the development of microbiome-based therapeutics, such as probiotics and prebiotics.
We explore their potential in treating conditions such as gastrointestinal disorders, immune-related diseases, and mental health.
Collaboration drives innovation in
this field, and we actively seek partnerships to enhance our research and development efforts.
Through the use of
next-generation sequencing
and bioinformatics, we advance microbiome diagnostics.
This enables precise identification and monitoring of microbial communities, allowing for personalized disease treatment.
Our goal is to unravel the connections between the human gut microbiome and health.
Through research, we identify microbial signatures as valuable biomarkers for various conditions. This knowledge enables us to develop personalized microbiome therapeutics for improved health outcomes.
bottom of page